Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women

Rosario Rossi1, Annachiara Nuzzo, Giorgia Origliani

  • 1Institute of Cardiology, Policlinico Hospital, University of Modena and Reggio Emilia, Modena, Italy. rossi.rosario@unimore.it

Insights

Brachial artery flow-mediated dilation (FMD) is a valuable tool for predicting cardiovascular events in post-menopausal women. Lower FMD levels significantly correlate with increased risk, offering incremental prognostic information beyond traditional risk factors.

Area of Science:

  • Cardiovascular Research
  • Endothelial Function Assessment
  • Preventive Cardiology

Background:

  • Conventional cardiovascular risk factors inadequately predict 50% of events.
  • Individualized risk assessment is crucial for primary prevention.
  • Endothelial function, measured by brachial artery flow-mediated dilation (FMD), may identify high-risk individuals.

Purpose of the Study:

  • To investigate the association between brachial artery flow-mediated dilation (FMD) and cardiovascular events.
  • To assess FMD's prognostic value in initially asymptomatic post-menopausal women.
  • To adjust for major cardiovascular risk factors in the analysis.

Main Methods:

  • Prospective study of 2,264 post-menopausal women (age 54 ± 6 years).
  • Follow-up duration of 45 ± 13 months.
  • Analysis of brachial artery flow-mediated dilation (FMD) tertiles and cardiovascular event rates.

Main Results:

  • A significant trend (p < 0.0001) showed increased cardiovascular event risk with lower FMD tertiles.
  • Women in the lowest FMD tertile (≤4.5%) had a 4.42-fold higher risk.
  • FMD significantly improved cardiovascular event prediction models when added to conventional risk factors.

Conclusions:

  • Brachial artery flow-mediated dilation (FMD) provides incremental prognostic information in post-menopausal women.
  • FMD knowledge enhances risk stratification for cardiovascular events.
  • This noninvasive measure aids in identifying individuals at higher risk.
Abstract

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.